Related Experiment Video

Updated: Jul 7, 2026

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium
04:05

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium

Published on: May 31, 2024

Pre-pouch ileitis after colectomy in paediatric ulcerative colitis

Carrie Slatter1, Safwat Girgis, Hien Huynh

  • 1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Stollery Children's Hospital, Edmonton, and Department of Pathology, University of Alberta, Edmonton, Alberta, Canada.

Acta Paediatrica (Oslo, Norway : 1992)
|February 5, 2008
PubMed

Insights

Terminal ileitis can occur in children with ulcerative colitis (UC) after colectomy and ileal pouch anal anastomosis (IPAA). This complication should not rule out a UC diagnosis, even if Crohn

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Surgical Complications

Background:

  • Colectomy with ileal pouch anal anastomosis (IPAA) offers curative potential for ulcerative colitis (UC).
  • Terminal ileitis is a rare, poorly documented postoperative complication of IPAA, particularly in pediatric patients.

Observation:

  • Two pediatric patients with medically refractory UC underwent colectomy with IPAA.
  • One year post-surgery, both presented with bloody diarrhea and weight loss.
  • Endoscopic and biopsy findings revealed acute-on-chronic inflammation in the pouch and terminal ileum.

Findings:

  • The inflammation showed a mixed inflammatory infiltrate without granulomas.
  • Terminal ileitis developed in pediatric patients following IPAA for UC.
  • This complication occurred despite efforts to rule out Crohn's disease.

Implications:

  • Terminal ileitis can occur in children with UC post-IPAA and does not exclude a UC diagnosis.
  • Further research is crucial to understand the pathogenesis of this uncommon condition.
  • Clinical management should consider terminal ileitis as a potential complication in pediatric UC patients post-IPAA.
Abstract

More Related Videos

Murine Ileocolic Bowel Resection with Primary Anastomosis08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...